The Richmond, California-based start-up has discontinued a phase 2 trial of its obesity drug azelaprag as a monotherapy and in combination with Eli Lillys blockbuster weight-loss therapy Zepbound (tirzepatide) after seeing signs of potential liver damage in patients
DSIP (Delta Sleep Inducing Peptide) is a neuropeptide that promotes slow-wave (delta) sleep architecture
The founders are targeting an exit in the next three to five years, with the hope of being acquired by a bigger pet food company for around 150M, they said on the show
Most women with PCOS are overweight or obese, which increases androgen secretion and affects metabolism and reproductive function
1 liter of fluids + L Carnitine + L Arginine + B12 + B Complex + Glutathione IV push Vitamin Sea $170 Vitamin C is essential for life and plays an integral part of forming blood vessels, muscles, cartilage, and collagen
Mirum CEO Chris Peetz said in a statement that Livmarli could have a transformational impact for patients with cholestatic pruritis associated with PFIC. March 11: In a press release Monday, Viatris and Mapi Pharma announced that the FDA has rejected their multiple sclerosis hopeful GA Depot 40, which the companies had proposed as a treatment for relapsing forms of the disease
.png)
